A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies
Conditions
- Lupus Erythematosus, Discoid
Interventions
- DRUG: Belimumab 1 mg/kg
- DRUG: Belimumab 10 mg/kg
- OTHER: Placebo
Sponsor
Human Genome Sciences Inc., a GSK Company
Collaborators